Ketamine Terminated Phase 2 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01957410A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
NCT01135758Study of Depression-Ketamine-Brain Function